These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 39099795)

  • 1. Construction and Evaluation of BAL-PTX Co-Loaded Lipid Nanosystem for Promoting the Anti-Lung Cancer Efficacy of Paclitaxel and Reducing the Toxicity of Chemotherapeutic Drugs.
    Chen T; Wei Y; Yin S; Li W; Wang Y; Pi C; Zeng M; Wang X; Chen L; Liu F; Fu S; Zhao L
    Int J Nanomedicine; 2024; 19():7775-7797. PubMed ID: 39099795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
    Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
    Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel.
    Zhang X; Wu Y; Zhang M; Mao J; Wu Y; Zhang Y; Yao J; Xu C; Guo W; Yu B
    Int J Nanomedicine; 2017; 12():8779-8799. PubMed ID: 29263668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylated pH-Responsive Liposomes for Enhancing the Intracellular Uptake and Cytotoxicity of Paclitaxel in MCF-7 Breast Cancer Cells.
    Nijhawan HP; Shyamsundar P; Prabhakar B; Yadav KS
    AAPS PharmSciTech; 2024 Sep; 25(7):216. PubMed ID: 39289249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.
    Jiménez-López J; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Cabeza L; Perazzoli G; Martin-Banderas L; Baeyens JM; Prados J; Melguizo C
    Pharmacol Res; 2019 Mar; 141():451-465. PubMed ID: 30634051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
    Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
    Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.
    Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W
    Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An optimized two-vial formulation lipid nanoemulsion of paclitaxel for targeted delivery to tumor.
    Chen L; Chen B; Deng L; Gao B; Zhang Y; Wu C; Yu N; Zhou Q; Yao J; Chen J
    Int J Pharm; 2017 Dec; 534(1-2):308-315. PubMed ID: 28986321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
    Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
    Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer cell membrane-camouflaged paclitaxel/PLGA nanoparticles for targeted therapy against lung cancer.
    Zhou J; Wan S; Wu Y; Hu H; Liu Y; Liao Z; Xu M; Wu J; Fan Q
    Biomed Pharmacother; 2024 Aug; 177():117102. PubMed ID: 38991303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.
    Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z
    Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel antitumor effect improvement in lung cancer and prevention of the painful neuropathy using large pegylated cationic liposomes.
    Jiménez-López J; Bravo-Caparrós I; Cabeza L; Nieto FR; Ortiz R; Perazzoli G; Fernández-Segura E; Cañizares FJ; Baeyens JM; Melguizo C; Prados J
    Biomed Pharmacother; 2021 Jan; 133():111059. PubMed ID: 33378963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity.
    Jian Y; Zhao M; Cao J; Fan T; Bu W; Yang Y; Li W; Zhang W; Qiao Y; Wang J; Wen A
    Drug Des Devel Ther; 2020; 14():2355-2370. PubMed ID: 32606603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
    Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J
    Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo.
    Yao S; Li L; Su XT; Wang K; Lu ZJ; Yuan CZ; Feng JB; Yan S; Kong BH; Song K
    J Exp Clin Cancer Res; 2018 Feb; 37(1):29. PubMed ID: 29478415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
    Lv W; Cheng L; Li B
    Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
    Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
    Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.